Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies
Antonio Di Stasi, Antonio Jiménez, Kentaro Minagawa, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Acute Myeloid Leukemia
Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield
New England Journal of Medicine (2015) Vol. 373, Iss. 12, pp. 1136-1152
Closed Access | Times Cited: 2803
Immune escape and immunotherapy of acute myeloid leukemia
Luca Vago, Ivana Gojo
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1552-1564
Open Access | Times Cited: 251
Engineering patient-specific cancer immunotherapies
Lindsay Scheetz, Kyong Soo Park, Qiao Li, et al.
Nature Biomedical Engineering (2019) Vol. 3, Iss. 10, pp. 768-782
Open Access | Times Cited: 178
Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 118
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Faroogh Marofi, Heshu Sulaiman Rahman, Zaid Al-Obaidi, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 113
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 368
Open Access | Times Cited: 150
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, et al.
Leukemia (2016) Vol. 31, Iss. 8, pp. 1788-1797
Open Access | Times Cited: 140
Immune suppression and reversal of the suppressive tumor microenvironment
Kanako Shimizu, Tomonori Iyoda, Masahiro Okada, et al.
International Immunology (2018) Vol. 30, Iss. 10, pp. 445-455
Closed Access | Times Cited: 140
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
P. Maslak, Tao Dao, Yvette Bernal, et al.
Blood Advances (2018) Vol. 2, Iss. 3, pp. 224-234
Open Access | Times Cited: 139
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
Eric S. Winer, Richard M. Stone
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 108
Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia
Raajit K. Rampal, María E. Figueroa
Haematologica (2016) Vol. 101, Iss. 6, pp. 672-679
Open Access | Times Cited: 106
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
Adam J. Lamble, Evan Lind
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 104
Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
Yuxin Liu, Jan Philipp Bewersdorf, Maximilian Stahl, et al.
Blood Reviews (2018) Vol. 34, pp. 67-83
Closed Access | Times Cited: 97
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
Yasushi Akahori, Linan Wang, Motohiro Yoneyama, et al.
Blood (2018) Vol. 132, Iss. 11, pp. 1134-1145
Open Access | Times Cited: 91
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
Grégory Ehx, Jean‐David Larouche, Chantal Durette, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 737-752.e10
Open Access | Times Cited: 82
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
Adam J. Lamble, Yoko Kosaka, Ted Laderas, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 25, pp. 14331-14341
Open Access | Times Cited: 79
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
Andrew M. K. Law, Elgene Lim, Christopher J. Ormandy, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 4, pp. R123-R144
Open Access | Times Cited: 83
Leveraging premalignant biology for immune-based cancer prevention
Avrum Spira, Mary L. Disis, John T. Schiller, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 39, pp. 10750-10758
Open Access | Times Cited: 63
Novel Approaches to Acute Myeloid Leukemia Immunotherapy
Ofrat Beyar‐Katz, Saar Gill
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5502-5515
Closed Access | Times Cited: 60
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Christian Augsberger, Gerulf Hänel, Wei Xu, et al.
Blood (2021) Vol. 138, Iss. 25, pp. 2655-2669
Open Access | Times Cited: 54
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
Eliana Ruggiero, Erica Carnevale, Aaron Prodeus, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 631
Open Access | Times Cited: 31
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 8
Vaccine therapy in hematologic malignancies
David Avigan, Jacalyn Rosenblatt
Blood (2018) Vol. 131, Iss. 24, pp. 2640-2650
Open Access | Times Cited: 47
Maintenance therapy in acute myeloid leukemia: advances and controversies
Jayastu Senapati, Tapan M. Kadia, Farhad Ravandi
Haematologica (2023)
Open Access | Times Cited: 15
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation
Carmen Di Grazia, Sarah Pozzi, Simona Geroldi, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 7, pp. 1242-1246
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top